Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men

Metabolism: Clinical and Experimental

Volumn 51, Issue 9, 2002, Pages 1206-1210

  Watts, Gerald F ^a   Chan, Dick C ^a   Barrett, P Hugh R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CARBON 13; FAT; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOTOPE; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMEN; ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CATABOLISM; COMPARTMENT MODEL; COMPUTER PROGRAM; COMPUTER SIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GAS CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; INSULIN RESISTANCE; ISOTOPE ANALYSIS; KINETICS; LIPOPROTEIN METABOLISM; LIVER; MALE; MASS SPECTROMETRY; MEASUREMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PERITONEUM; PREDICTION; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SCORING SYSTEM; SUBCUTANEOUS TISSUE; TRIACYLGLYCEROL BLOOD LEVEL; VARIANCE; VOLUNTEER;

EID: 0036737530     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.34718     Document Type: Article

References (35)

1. Depres JP, Moorjani S, Lupien PJ, et al: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Atherosclerosis 10:497-511, 1990
2. Lapidus L, Bengtsson C, Larsson B, et al: Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
3. Garg A: The role of body fat distribution in insulin resistance, in Reaven GM, Laws A (eds): Contemporary Endocrinology: Insulin Resistance. Totowa, NJ, Humana, 1999, pp 83-96
4. Bjorntorp P: "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990
5. Fujioka S, Matsuzawa Y, Tokunaga K, et al: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987
6. Abate N, Garg A, Peshock RM, et al: Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96:88-98, 1995
7. Caprio S, Hyman LD, Limb C, et al: Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 269:E118-126, 1995
8. Packard CJ: Understanding coronary heart disease as a consequence of detective regulation of apolipoprotein B metabolism. Curr Opin Lipidol 10:237-244, 1999
9. Kesaniemi YA, Beltz WF, Grundy SM: Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest 76:586-595, 1985
10. Lamarche B, Moorjani S, Lupien PJ, et al: Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 94:273-278, 1996
11. Thompson GR, Naoumova R, Watts GF: Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res 37:439-447, 1996
12. Sniderman AD, Cianflone K: Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb Vasc Biol 13:629-636, 1993
13. Watts GF, Cummings MH, Keel JM, et al: Acute hyperinsulinemia decreases hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in normolipidaemic, non-diabetic subjects. Endocrinol Metab 3:253-263, 1996
14. Lewis GF, Uffelman KD, Szeto LW, et al: Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166, 1995
15. Deurenberg P,Yap M: The assessment of obesity: Methods for measuring body fat and global prevalence of obesity. Bailliere Clin Endocrinol Metab 13:1-11, 1999
16. Abate N, Garg A, Peshock RM, et al: Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 45:1684-1693, 1996
17. Riches FM, Watts GF, Hua J, et al: Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. J Clin Endocrinol Metab 84:2854-2861, 1999
18. Ross R, Leger L, Morris D, et al: Quantification of adipose tissue by MRI: Relationship with anthropometric variables. J Appl Physiol 72: 787-795, 1992
19. Watts GF, Riches FM, Kelly JM, et al: Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men. Clin Exp Pharmacol Physiol 24:556-562, 1997
20. Cummings, MH, Watts GF, Lumb PJ, et al: Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma. J Clin Pathol 47:176-178, 1994
21. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
22. Bonora E, Del Prato S, Bonadonna RC, et al: Total body fat content and fat topography are associated differently with in vivo glucose metabolism in non-obese and obese nondiabetic women. Diabetes 41:1151-1159, 1992
23. Malstrom R, Packard CJ, Watson TD, et al: Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454-1464, 1997
24. Kissebah AH, Alfarsi S, Adams PW, et al: Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12:563-571, 1976
25. Riches FM, Watts GF, Naoumova RP, et al: Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Int J Obes 22:414-423, 1998
26. Carlson LA, Hallberg D: Basal lipolysis and effects of norepinephrine and prostaglandin E on lipolysis in human subcutaneous and omental adipose tissue. J Lab Clin Med 71:368-377, 1968
27. Carlson LA, Hallberg D, Micheli H: Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand 185:465-469, 1969
28. Ferrannini E, Barrett EJ, Bevilacqua S, et al: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
29. Bolinder J, Kager L, Ostman J, et al: Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123, 1983
30. Smith U, Hammersten J, Bjorntorp P, et al: Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest 9:327-332, 1979
31. Ostman J, Arner P, Engfeldt P, et al: Regional differences in the control of lipolysis in human adipose tissue. Metabolism 28:1198-1205, 1979
32. Maheux P, Azhar S, Kern PA, et al: Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 40:850-858, 1997
33. Laws A: Insulin and dyslipidaemia: Implications for coronary heart disease risk, in Reaven GM, Laws A (eds): Contemporary Endocrinology: Insulin Resistance. Totowa, NJ, Humana, 1999, pp 267-280
34. Lukaski HC, Johnson PE, Bolonchuk WW, et al: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 1985
35. Watts GF, Riches FM, Humphries SE, et al: Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. J Lipid Res 41:481-488, 2000